FDAnews Drug Daily Bulletin

July 24, 2012 | Vol. 9 No. 144

Derma Sciences Announces Issuance of Two New U.S. Patents For DSC127

Derma Sciences announced the issuance of patents 8,207,233 and 8,207,234 by the U.S. PTO. These patents provide additional intellectual property protection for the company’s investigational drug DSC127 by describing the angiotensin peptide in a specific formulation and a method of using the same to treat diabetic foot ulcers.
MarketWatch

Register Now
Print This Page
Email This Article
RSS
Archives

Full Issue FDA Denies Deston’s Petition to Market Ear Infection Drug DTC Marketing Study Implies Doctors Overprescribe Statins Pfizer Halts Phase III Trial of Lyphoma Drug After Interim Analysis

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.